Alan Ezekowitz is currently a venture partner at Third Rock Ventures, LLC, and also serves as Entrepreneur in Residence at Cardinal Partners. From 2011 to 2019, Dr. Ezekowitz was Co-Founder and CEO of Abide Therapeutics, Inc., which was acquired by Lundbeck Pharmaceuticals Ltd. in 2019. Prior to co-founding Abide, he was a Senior Vice President at Merck Research Laboratories responsible for the Bone, Respiratory, Immunology, Inflammation and Dermatology franchises. Prior to his time at Merck, Dr. Ezekowitz was the Chief of Pediatric Services at Partner Healthcare System, Inc. (1999 to 2006) and at the Massachusetts General Hospital (1995-2006). From 1995 to 2006, he was the Charles Wilder Professor of Pediatrics at Harvard Medical School. He currently serves on the Board of Directors of Fulcrum Therapeutics, Inc. Dr. Ezekowitz was born in South Africa, educated at the University of Cape Town in South Africa and earned his DPhil at the University of Oxford in the United Kingdom.